Amphastar Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.25 billion, with shareholders equity totaling $814.55 million.
The company employs approximately 1.976 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, Amphastar Pharmaceuticals Inc. reported $745.79 million in revenue, generating net income of $98.96 million.
Key financial metrics include a P/E ratio of 12.65, a price-to-book (P/B) ratio of 1.54, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker AMPH.